Mutations in ASXL2 and ASXL3 have not been found in myeloid diseases so far, but ASXL2-MYST3 and EPC1-ASXL2 fusions have been identified in myelodysplastic syndrome and T-cell acute leukemia, respectively [45,46]. This evidence concerns the gene ASXL2 and T-cell acute lymphoblastic leukemia.